Clinical Trial: Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Study Status: Completed
Recruit Status: RECRUITING
Condition: Pancreatic Cancer
Study Type: INTERVENTIONAL
Official Title: A Prospective Trial of Stereotactic Adaptive Radiation Therapy for Borderline Resectable/Locally Advanced Pancreatic Cancer: An Individualized Approach to Minimizing Gastrointestinal Toxicity (AR
Brief Summary:
This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for treatment of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity.The study will evaluate GI toxicity, overall survival, local control, quality of life, and workflow metrics.
Read more